Skip to main content
Yoshifumi Naka, MD, Thoracic Surgery, New York, NY

YoshifumiNakaMD

Thoracic Surgery New York, NY

Adult Cardiac Surgery, Cardiopulmonary Transplantation, Cardiovascular Surgery

Cardiac surgery at New York Presbyterian Hospital

Overview of Dr. Naka

Dr. Yoshifumi Naka is a thoracic surgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Osaka University Medical School and has been in practice 33 years. He is one of 58 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 143 doctors at New York-Presbyterian Hospital who specialize in Thoracic Surgery. He also speaks multiple languages, including Japanese. He has more than 100 publications and over 500 citings.

Education & Training

  • Osaka University Medical School
    Osaka University Medical SchoolClass of 1984
  • Osaka University
    Osaka UniversityBachelors, Pre-med, 1978 - 1968

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1999 - 2026

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2006-2014
  • New York Magazine: Top Doctors Castle Connolly, 2005-2009, 2011-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019  
    Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
  • VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?  
    Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
  • Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support  
    Wasson LT, Yuzefpolskaya M, Wakabayashi M, Takayama H, Naka Y, Uriel N, Jorde UP, Demmer RT, Colombo PC, Heart Fail Rev., 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Authored Content

  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020

Press Mentions

  • NewYork-Presbyterian Expands Heart Transplant and Heart Failure Services
    NewYork-Presbyterian Expands Heart Transplant and Heart Failure ServicesNovember 1st, 2022
  • NewYork-Presbyterian Expands Heart Transplant and Heart Failure Services
    NewYork-Presbyterian Expands Heart Transplant and Heart Failure ServicesNovember 1st, 2022
  • New Data Shows Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients
    New Data Shows Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure PatientsAugust 29th, 2022
  • Join now to see all

Other Languages

  • Japanese